Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 31;29(12):1429-32.
doi: 10.1097/QAD.0000000000000658.

The need for treatment interruption studies and biomarker identification in the search for an HIV cure

Jonathan Z Li  1 , Davey M Smith, John W Mellors
Affiliations

The need for treatment interruption studies and biomarker identification in the search for an HIV cure

Jonathan Z Li et al. AIDS. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

J.Z.L. has served as a consultant for Quest Diagnostics, SeraCare Life Sciences and TherapyEdge. J.W.M is a consultant to Gilead Sciences and a shareholder of RFS Pharmaceuticals. D.M.S. has served as a consultant for Hologic and Testing Talent Services.

Comment in

References

    1. Fagard C, Oxenius A, Gunthard H, Garcia F, Le Braz M, Mestre G, et al. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. Arch Intern Med. 2003;163:1220–1226. - PubMed
    1. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283–2296. - PubMed
    1. Routy JP, Boulassel MR, Nicolette CA, Jacobson JM. Assessing risk of a short-term antiretroviral therapy discontinuation as a read-out of viral control in immune-based therapy. J Med Virol. 2012;84:885–889. - PubMed
    1. Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med. 2014;370:901–910. - PMC - PubMed
    1. Schooley RT, Spritzler J, Wang H, Lederman MM, Havlir D, Kuritzkes DR, et al. AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. J Infect Dis. 2010;202:705–716. - PMC - PubMed

Publication types